MARROSU, MARIA GIOVANNA
 Distribuzione geografica
Continente #
EU - Europa 411.594
NA - Nord America 24.598
AS - Asia 9.063
SA - Sud America 1.195
Continente sconosciuto - Info sul continente non disponibili 763
AF - Africa 195
OC - Oceania 25
Totale 447.433
Nazione #
IT - Italia 405.637
US - Stati Uniti d'America 24.243
SG - Singapore 3.531
CN - Cina 3.456
UA - Ucraina 1.817
SE - Svezia 1.110
BR - Brasile 937
FI - Finlandia 700
DE - Germania 669
GB - Regno Unito 662
VN - Vietnam 653
FR - Francia 503
HK - Hong Kong 318
CA - Canada 208
IN - India 208
KR - Corea 175
BD - Bangladesh 136
NL - Olanda 100
AR - Argentina 80
IQ - Iraq 75
RU - Federazione Russa 71
TR - Turchia 65
PK - Pakistan 61
JP - Giappone 59
MX - Messico 59
ES - Italia 50
ZA - Sudafrica 49
EC - Ecuador 46
MA - Marocco 44
PL - Polonia 43
BE - Belgio 42
AT - Austria 38
VE - Venezuela 37
ID - Indonesia 35
CO - Colombia 34
SA - Arabia Saudita 34
UZ - Uzbekistan 33
CL - Cile 27
PH - Filippine 27
IL - Israele 24
AU - Australia 21
EU - Europa 21
CZ - Repubblica Ceca 20
JM - Giamaica 20
MY - Malesia 20
AZ - Azerbaigian 18
IR - Iran 18
DZ - Algeria 17
JO - Giordania 17
KE - Kenya 16
LT - Lituania 16
TH - Thailandia 14
TN - Tunisia 14
CH - Svizzera 12
CR - Costa Rica 12
EG - Egitto 12
UY - Uruguay 12
HR - Croazia 11
IE - Irlanda 11
RO - Romania 11
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
ET - Etiopia 9
MU - Mauritius 9
NP - Nepal 9
OM - Oman 9
BG - Bulgaria 8
PS - Palestinian Territory 8
TW - Taiwan 8
BO - Bolivia 7
CU - Cuba 7
DO - Repubblica Dominicana 7
GT - Guatemala 7
HN - Honduras 7
LB - Libano 7
PA - Panama 7
DK - Danimarca 6
KG - Kirghizistan 6
KZ - Kazakistan 6
GR - Grecia 5
HU - Ungheria 5
NG - Nigeria 5
PT - Portogallo 5
RS - Serbia 5
SN - Senegal 5
SV - El Salvador 5
GA - Gabon 4
GE - Georgia 4
NO - Norvegia 4
PE - Perù 4
PR - Porto Rico 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
EE - Estonia 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 446.643
Città #
Cagliari 398.260
Uta 5.912
Fairfield 2.540
Woodbridge 2.147
Ashburn 2.070
Singapore 1.713
Chandler 1.537
Houston 1.415
San Jose 1.278
Wilmington 1.125
Ann Arbor 1.044
Seattle 998
Boardman 958
Dallas 894
Jacksonville 891
Cambridge 849
Nyköping 707
Beijing 636
Helsinki 399
Dearborn 393
Nanjing 354
Los Angeles 336
Santa Clara 289
Hong Kong 286
Lauterbourg 279
New York 270
Council Bluffs 249
Boston 248
The Dalles 246
Hefei 238
Shanghai 208
Ho Chi Minh City 206
Buffalo 189
Milan 174
Seoul 166
Hanoi 140
San Diego 134
Shenyang 130
Munich 125
Guangzhou 108
Nanchang 106
Toronto 106
Hebei 90
Redwood City 87
São Paulo 87
Changsha 86
Jiaxing 86
Norwalk 84
London 81
Verona 80
Washington 75
Chicago 67
Tianjin 67
Orem 66
Atlanta 65
Sassari 64
Columbus 63
Redondo Beach 60
Rome 50
Brooklyn 47
Jinan 45
Mountain View 45
Zhengzhou 45
Hangzhou 44
Phoenix 43
Tokyo 43
Dong Ket 40
Frankfurt am Main 39
Montreal 37
Ningbo 37
Warsaw 37
Da Nang 35
Stockholm 33
Auburn Hills 31
Brussels 31
Tashkent 30
Johannesburg 29
Orange 29
Taizhou 29
Chennai 28
Kunming 28
Pune 28
Rio de Janeiro 28
Haiphong 27
San Francisco 27
Amsterdam 24
Baghdad 24
Istanbul 24
Nuremberg 24
Florence 23
Belo Horizonte 21
Denver 21
Manchester 21
Porto Alegre 21
Curitiba 20
Miami 20
Wuhan 20
Newark 19
Baku 18
Dhaka 18
Totale 432.844
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.164
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.994
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.253
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.947
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.590
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.506
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.497
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.410
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.313
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.292
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.224
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.221
Overexpression of the cytokine BAFF and autoimmunity risk 4.141
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.056
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.026
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.943
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.901
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.847
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.845
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.832
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.807
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.736
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.716
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.672
Walking improvements with nabiximols in patients with multiple sclerosis 3.654
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.624
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.617
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.602
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.594
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.446
Dynamical insights into the differential characteristics of Mycobacterium avium subsp. paratuberculosis peptide binding to HLA-DRB1 proteins associated with multiple sclerosis 3.425
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.414
Impact of the media on future hope in multiple sclerosis 3.394
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.323
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.319
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.300
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.245
Oral agents in multiple sclerosis 3.216
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.215
Influence of treatments in multiple sclerosis disability: a cohort study 3.192
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.124
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.110
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity 3.107
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.065
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.054
Refining the connection between gait and cognition: training the body to improve the brain 2.990
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.984
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.981
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.965
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.957
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.888
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.880
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.820
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.732
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.681
Postural adaptation during a Nintendo Wii balance training 2.676
Perception of risk and shared decision making process in multiple sclerosis 2.658
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.644
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.618
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.579
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.564
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients 2.543
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.543
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.504
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.457
Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia 2.445
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.414
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.344
The cohort of the multiple sclerosis center of Cagliari 2.340
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.336
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.323
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement 2.314
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.313
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.310
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.295
Induction and escalation therapies in multiple sclerosis 2.290
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.279
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.261
Cognitive screening in patients with amyotrophic lateral sclerosis in early stages 2.255
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.242
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.108
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.075
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.070
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 2.067
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 2.061
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 2.059
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 2.040
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.030
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 2.024
The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone 1.994
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.993
The Italian multiple sclerosis register 1.939
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 1.935
Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients 1.924
Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations 1.921
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.903
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.896
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.892
The risk of bipolar disorders in multiple sclerosis 1.888
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.877
Totale 303.094
Categoria #
all - tutte 575.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 575.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216.388 0 1.431 847 1.601 1.589 1.120 848 946 1.793 1.920 2.292 2.001
2022/202324.658 2.328 3.506 3.299 1.960 1.903 2.565 1.003 2.208 1.456 1.527 1.769 1.134
2023/202425.097 1.699 1.364 900 1.873 2.585 3.910 2.671 2.197 1.242 2.128 2.423 2.105
2024/202566.661 22.106 21.004 7.602 4.023 2.620 2.703 3.648 377 671 642 586 679
2025/202615.778 1.022 694 1.757 1.353 1.164 1.241 2.701 1.193 1.178 1.614 1.009 852
2026/2027748 332 416 0 0 0 0 0 0 0 0 0 0
Totale 447.433